NATERA, INC. Defined Contribution Plan, Cost
NATERA, INC. (NTRA) reported Defined Contribution Plan, Cost of $15.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-27
- NATERA, INC. defined contribution plan, cost for fiscal 2025 was $15.30M, a 42.99% increase from fiscal 2024.
- NATERA, INC. defined contribution plan, cost for fiscal 2024 was $10.70M, a 24.42% increase from fiscal 2023.
- NATERA, INC. defined contribution plan, cost for fiscal 2023 was $8.60M, a 5.49% decline from fiscal 2022.
- NATERA, INC. defined contribution plan, cost for fiscal 2022 was $9.10M.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $15.30M 10-K · filed 2026-02-27 |
| 2024-12-31 | $10.70M 10-K · filed 2026-02-27 |
| 2023-12-31 | $8.60M 10-K · filed 2026-02-27 |
| 2022-12-31 | $9.10M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |